Origen de la red de primer grado John J Horan.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a John J Horan a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| IMS HEALTH, INC. | Data Processing Services | Chief Operating Officer Director/Board Member | |
| IBEX TECHNOLOGIES | Medical Specialties | Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Syneos Health NC LLC
 Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Syneos Health LLC operates therapeutically focused global contract research organization. It provides pharma and biotech services. The firm specializes in the hematology, immunology and inflammation infectious diseases, oncology, ophthalmology, cardiovascular, CNS analgesia, CNS neurology, CNS psychiatry, endocrinology, and gastroenterology and hepatology. The company was founded by Kenneth A. Selzer in 1985 and is headquartered in Raleigh, NC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | President | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Founder President | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SCYNEXIS, INC. | Pharmaceuticals: Major | Chairman | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Director/Board Member | |
| The University of Chicago | College/University | Graduate Degree Director/Board Member | |
| University Of Dundee | College/University | Undergraduate Degree | |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co. LLC is a venture capital firm founded by Lawrence Miller and Paul Howard in 1999. It is headquartered in Newton, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Tasmania | College/University | Doctorate Degree | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| FasterCures | Corporate Officer/Principal | ||
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Director/Board Member | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Private Equity Investor | |
| Infinity Discovery, Inc. | President | ||
Stand Up To Cancer
 Stand Up To Cancer Miscellaneous Commercial ServicesCommercial Services Stand Up To Cancer (SU2C) is a non-profit organization that raises funds to accelerate cancer research and bring new therapies to patients quickly. SU2C is based in Los Angeles, CA. Established in 2008 by media and entertainment leaders, SU2C engages the public in supporting a collaborative model of cancer research, increasing awareness about cancer prevention, and highlighting progress in the fight against the disease. The organization has over 3,000 scientists from more than 210 institutions involved in SU2C-funded research projects. The American Association for Cancer Research (AACR) and a scientific advisory committee oversee grants administration and provide expert review of research progress. | Miscellaneous Commercial Services | Chief Executive Officer | |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Founder | |
| MIT Sloan School of Management | College/University | Graduate Degree Masters Business Admin | |
| Princess Margaret Cancer Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ELICIO THERAPEUTICS, INC. | Biotechnology | Chairman |
Estadísticas
Internacional
| Estados Unidos | 38 |
| Canadá | 8 |
| Israel | 4 |
| Suiza | 2 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 31 |
| Consumer Services | 7 |
| Finance | 6 |
| Commercial Services | 5 |
| Technology Services | 2 |
Operativa
| Director/Board Member | 220 |
| Independent Dir/Board Member | 63 |
| Corporate Officer/Principal | 60 |
| Chairman | 33 |
| President | 33 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Myrtle Potter | 41 |
| Wayne P. Yetter | 28 |
| Julian Adams | 23 |
| Daniel R. Martin | 22 |
| Judy Lewent | 19 |
| Richard Kender | 17 |
| J. Carroll | 17 |
| Ed M. Scolnick | 17 |
| Michael Atieh | 16 |
| Timothy Proctor | 16 |
| George Morrow | 16 |
| Vijay Samant | 15 |
| C. Boyd Clarke | 15 |
| Richard Henriques | 15 |
| Abraham E. Cohen | 14 |
- Bolsa de valores
- Insiders
- John J Horan
- Conexiones Empresas
